Go East, young biotech

You might call it a new Silk Road. Just like Marco Polo back in the 13th century, intrepid explorers from the West are once again beating a path to the Far East in search of China's great riches. Only this time, the profits won't come from jade or exotic spices; they're in the sciences.For basic scientists in Europe and the United States, China has long represented an enormous opportunity for collaboration. But a flurry of recent news from agencies pushing stronger links with China, plus new sup

Written byStephen Pincock
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

You might call it a new Silk Road. Just like Marco Polo back in the 13th century, intrepid explorers from the West are once again beating a path to the Far East in search of China's great riches. Only this time, the profits won't come from jade or exotic spices; they're in the sciences.

For basic scientists in Europe and the United States, China has long represented an enormous opportunity for collaboration. But a flurry of recent news from agencies pushing stronger links with China, plus new support from China's government, suggests interest is picking up pace. For the biotech industry, this is good news.

In late July, for example, Germany's Helmholtz Association of National Research Centres opened a Chinese office-only its second overseas office after Brussels-with the aim of boosting collaboration between researchers at its 15 centers and their Chinese counterparts.

"Given the euphoric mood and the dynamism amongst ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies